In early trade on Friday, these stocks dropped by as much as 3%, with the Nifty Auto and Nifty Pharma indices trading lower ...
Investors in pharma and auto stocks are anxious ahead of the April 2 deadline for US tariffs. Despite a 6% fall over three ...
Addressing the calculation of patent term extensions (PTEs) under the Hatch-Waxman Act, the US Court of Appeals for the Federal Circuit affirmed ...
U.S. President Trump imposes 25% tariff on auto imports, spotlight on pharma imports, Indian industry at risk.
Shares of Aurobindo Pharmaceuticals dropped 2% to a day's low of Rs 1,132.75, while Ipca Laboratories fell 2.7% to Rs ...
Ajanta Pharma Ltd.(down 1.53 per cent), Dr. Reddy's Laboratories Ltd.(down 1.35 per cent), Aurobindo Pharma Ltd.(down 1.0 ...
On March 13, 2025, the Federal Circuit issued a decision in Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc., No. 23-2254 (Fed. Cir. 2025) ...
“We are excited to collaborate with Scienture to enhance its commercial effectiveness,” said Paul Mignon, President, Deployment Solutions, Syneos Health. “Our team is committed to delivering tailored ...
Violations highlight growing concerns over the unchecked rise in medicine prices and their impact on affordability ...
Stocks like Reliance Industries, Apollo Hospitals Enterprise, Power Grid Corporation, Allied Blenders and Distillers, ...
Experts underestimated Trump's seriousness on tariffs; Indian auto and pharma sectors brace for impact, while steel remains ...
Curateq Biologics, a wholly owned subsidiary of Aurobindo Pharma, has allotted 4,125,055 Compulsory Convertible Preference Shares (CCPSs) of Rs.10/- each to Dr. Satakarni Makkapati on 20 March 2025.